Dr. Richards is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 Chicago Ave
# Children
Minneapolis, MN 55404Phone+1 612-813-5940Fax+1 612-813-6325
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 2000 - 2003
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1997 - 2000
- University of Michigan Medical SchoolClass of 1997
Certifications & Licensure
- MN State Medical License 2003 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Roles: Contact
Publications & Presentations
PubMed
- 17 citationsThree-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.Alan S Wayne, Van Huynh, Nobuko Hijiya, Rayne H Rouce, Patrick A Brown
Haematologica. 2023-03-01 - 11 citationsLangerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib.Yoav H. Messinger, Bruce Bostrom, Damon R Olson, Nathan Gossai, Lane H. Miller
Pediatric Blood & Cancer. 2020-12-01 - 7 citationsSymptomatic Hyperammonemia With Erwinia chrysanthemi-derived Asparaginase in Pediatric Leukemia Patients.Nathan Gossai, Michael Richards, Lara Boman, Yoav H. Messinger, Sara Gernbacher
Journal of Pediatric Hematology/oncology. 2018-05-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: